Pentoxifylline vs Placebo or no active treatment
Difficulty in swallowing (participant-reported proxy) · People of any age with a confirmed diagnosis, by clinical examination and biopsy, of oral submucous fibrosis (OSF)
Pentoxifylline led to lower difficulty in swallowing (participant-reported proxy) compared with placebo or no active treatment; GRADE not reported.
1 finding from 1 review
- OR 0.42 [0.19, 0.92]1 study · 106 participantsGRADE not reported